Suppr超能文献

体外抗微生物根管内药物对乳牙中白色念珠菌和粪肠球菌的疗效。

Efficacy of in vitro antimicrobial intracanal medicaments against C. albicans and E. faecalis in primary teeth.

作者信息

Rêgo Emily Feitosa, Rosário Yedda Maria Ribeiro Vasconcelos, Gleiser Rogerio, Ferreira-Pereira Antônio, Portela Maristela Barbosa, Primo Laura Guimarães

机构信息

Universidade Federal do Rio de Janeiro - UFRJ, School of Dentistry, Department of Pediatric Dentistry and Orthodontics, Rio de Janeiro, RJ, Brazil.

Universidade Federal do Rio de Janeiro - UFRJ, Institute of Microbiology Paulo de Goes, Department of General Microbiology, Rio de Janeiro, RJ, Brazil.

出版信息

Braz Oral Res. 2024 Dec 20;38:e133. doi: 10.1590/1807-3107bor-2024.vol38.0133. eCollection 2024.

Abstract

To exclusively evaluate, in vitro, the efficacy of five intracanal medicaments against Candida albicans and Enterococcus faecalis in infected single-rooted primary teeth. Forty-three teeth were selected, out of which 42 were simultaneously contaminated with C. albicans and E. faecalis, verified by measuring the initial quantification (IQ), whereas one tooth was used as sterile control. Forty-two teeth were then randomly assigned to six groups (n = 7 teeth in each); one was the control group, while the others received calcium hydroxide (CH), camphorated paramonochlorophenol (CMCP), CH/CMCP, chlorhexidine (CHX), or iodoform paste (IP). Two samples from each group were then randomly selected and evaluated under a scanning electron microscope along with the sterile control (n = 1) for qualitative analyses (n = 13). The remaining samples (n = 30) were collected after 7 days of intracanal medicaments (final quantification - FQ) and 7 days after medicament removal (residual quantification - RQ). ANOVA and Tukey's and c2 tests (p £ 0.05) were performed for the statistical analysis. All the medicaments, except CMCP, significantly reduced the levels of C. albicans from IQ to FQ (p = 0.046). Only CHX (p = 0.000) and IP (p = 0.007) showed a significant reduction from IQ to FQ against E. faecalis. The 2% CHX and IP demonstrated a favorable performance as an intracanal medicament, with a good antimicrobial activity against C. albicans and E. faecalis.

摘要

为了在体外专门评估五种根管内药物对感染的单根乳牙中白色念珠菌和粪肠球菌的疗效。选取了43颗牙齿,其中42颗同时被白色念珠菌和粪肠球菌污染,通过测量初始定量(IQ)进行验证,而一颗牙齿用作无菌对照。然后将42颗牙齿随机分为六组(每组n = 7颗牙齿);一组为对照组,其他组分别接受氢氧化钙(CH)、樟脑对氯苯酚(CMCP)、CH/CMCP、氯己定(CHX)或碘仿糊剂(IP)。然后从每组中随机选取两个样本,并与无菌对照(n = 1)一起在扫描电子显微镜下进行评估,用于定性分析(n = 13)。在根管内用药7天后(最终定量 - FQ)和去除药物7天后(残留定量 - RQ)收集其余样本(n = 30)。进行方差分析、Tukey检验和卡方检验(p≤0.05)用于统计分析。除CMCP外,所有药物均能显著降低白色念珠菌从IQ到FQ的水平(p = 0.046)。只有CHX(p = 0.000)和IP(p = 0.007)在针对粪肠球菌时显示出从IQ到FQ的显著降低。2%的CHX和IP作为根管内药物表现出良好的性能,对白色念珠菌和粪肠球菌具有良好的抗菌活性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验